93 related articles for article (PubMed ID: 9446207)
1. [Long-term survival of 2 cases of hemochromatosis respectively homozygous for His63Asp and Cys282Tyr mutations].
Samii K; Darbellay R; Trachsel H; Beris P
Schweiz Med Wochenschr; 1997 Nov; 127(45):1867-70. PubMed ID: 9446207
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
Bassett ML; Halliday JW; Ferris RA; Powell LW
Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
4. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
5. Two Dutch families with hereditary hyperferritinaemia-cataract syndrome and heterozygosity for an HFE-related haemochromatosis gene mutation.
Simsek S; Nanayakkara PW; Keek JM; Faber LM; Bruin KF; Pals G
Neth J Med; 2003 Sep; 61(9):291-5. PubMed ID: 14692443
[TBL] [Abstract][Full Text] [Related]
6. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients.
Piperno A; Arosio C; Fargion S; Roetto A; Nicoli C; Girelli D; Sbaiz L; Gasparini P; Boari G; Sampietro M; Camaschella C
Hepatology; 1996 Jul; 24(1):43-6. PubMed ID: 8707280
[TBL] [Abstract][Full Text] [Related]
7. [Significance of "minor" genetic mutations in hereditary hemochromatosis: 2 case reports].
Maccari S; Plancher AC
Ann Ital Med Int; 2000; 15(3):221-5. PubMed ID: 11059064
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
Grigg AP; Bhathal PS
Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
[TBL] [Abstract][Full Text] [Related]
9. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
10. [Primary hemochromatosis in asymptomatic young patients].
Muñoz Sánchez MM; Núñez Martínez O; Torres Orgaz A; del Castillo Rueda A; de Portugal Alvarez J
An Med Interna; 2000 Jan; 17(1):9-12. PubMed ID: 10730398
[TBL] [Abstract][Full Text] [Related]
11. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
Kom GD; Schwedhelm E; Nielsen P; Böger RH
Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis.
Barton JC; Shih WW; Sawada-Hirai R; Acton RT; Harmon L; Rivers C; Rothenberg BE
Blood Cells Mol Dis; 1997; 23(1):135-45; discussion 145a-b. PubMed ID: 9215758
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemochromatosis.
Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up.
Miniero R; Tardivo I; Roetto A; De Gobbi M
Pediatr Hematol Oncol; 2005 Mar; 22(2):163-6. PubMed ID: 15805002
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of primary hemochromatosis].
Swinkels DW; Marx JJ
Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary hemocromatosis].
Franchini M; Veneri D
Recenti Prog Med; 2004 Oct; 95(10):457-62. PubMed ID: 15560291
[TBL] [Abstract][Full Text] [Related]
17. HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women.
van der A DL; Peeters PH; Grobbee DE; Roest M; Voorbij HA; van der Schouw YT
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):60-8. PubMed ID: 16399493
[TBL] [Abstract][Full Text] [Related]
18. Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.
Piéroni L; Mekhloufi F; Thiolières JM; Hainque B; Herson S; Jardel C
Clin Chim Acta; 2005 Mar; 353(1-2):61-6. PubMed ID: 15698591
[TBL] [Abstract][Full Text] [Related]
19. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.
Florkowski CM; George PM; Willis JA; Stott MK; Burt MJ; Upton JD; Nesbit J; Walmsley TA; Scott RS
Diabetes Res Clin Pract; 1999 Mar; 43(3):199-203. PubMed ID: 10369430
[TBL] [Abstract][Full Text] [Related]
20. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
